[Preleukemia myelodysplastic syndrome after chemotherapy for multiple myeloma: "a new case"].
Raya Sánchez
J M
JM
González Brito
G
G
Marsá Vila
L
L
Brito Barroso
M L
ML
Hernández Nieto
L
L
D000368:Aged; D000754:Anemia, Refractory, with Excess of Blasts / Q000139:chemically induced*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D002330:Carmustine / Q000008:administration & dosage; D003520:Cyclophosphamide / Q000008:administration & dosage; D006801:Humans; D008297:Male; D008558:Melphalan / Q000008:administration & dosage / Q000009:adverse effects; D008727:Methotrexate / Q000008:administration & dosage; D009101:Multiple Myeloma / Q000188:drug therapy*; D011241:Prednisone / Q000008:administration & dosage; D012306:Risk; D014750:Vincristine / Q000008:administration & dosage
D014750:Vincristine; D003520:Cyclophosphamide; D008558:Melphalan; D002330:Carmustine; D011241:Prednisone; D008727:Methotrexate
Síndrome mielodisplásico preleucémico tras quimioterapia por mieloma múltiple: "un nuevo caso".